NeuroPace, Inc. (NASDAQ:NPCE) Receives $16.60 Consensus PT from Brokerages

Key Points

• NeuroPace, Inc. has received a consensus rating of "Moderate Buy" from analysts, with one hold recommendation and five buy recommendations.
• The company reported a quarterly earnings loss of ($0.26) per share, missing the consensus estimate of ($0.24), despite revenue exceeding estimates at $23.52 million.
• Large institutional investors have increased their stakes in NeuroPace, with a significant 83.6% increase in holdings from Ameritas Investment Partners in the second quarter.

Shares of NeuroPace, Inc. (NASDAQ:NPCE - Get Free Report) have received an average recommendation of "Moderate Buy" from the six analysts that are currently covering the firm, Marketbeat reports. One research analyst has rated the stock with a hold rating and five have issued a buy rating on the company. The average 1-year target price among analysts that have covered the stock in the last year is $16.60.

A number of brokerages have issued reports on NPCE. Zacks Research lowered shares of NeuroPace from a "strong-buy" rating to a "hold" rating in a report on Wednesday, August 13th. Wells Fargo & Company cut their price objective on shares of NeuroPace from $17.00 to $15.00 and set an "overweight" rating on the stock in a research report on Wednesday, August 13th. Finally, HC Wainwright started coverage on NeuroPace in a research report on Wednesday, May 28th. They issued a "buy" rating and a $18.00 price objective on the stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in NPCE. Ameritas Investment Partners Inc. boosted its stake in shares of NeuroPace by 83.6% during the second quarter. Ameritas Investment Partners Inc. now owns 2,455 shares of the company's stock valued at $27,000 after purchasing an additional 1,118 shares in the last quarter. BNP Paribas Financial Markets bought a new stake in NeuroPace during the 4th quarter valued at $29,000. Legal & General Group Plc boosted its position in NeuroPace by 86.0% during the second quarter. Legal & General Group Plc now owns 2,679 shares of the company's stock valued at $30,000 after purchasing an additional 1,239 shares in the last quarter. Quantbot Technologies LP bought a new stake in NeuroPace during the second quarter valued at about $35,000. Finally, GAMMA Investing LLC bought a new stake in NeuroPace during the first quarter valued at about $53,000. 78.83% of the stock is currently owned by institutional investors.

NeuroPace Stock Performance

NeuroPace stock traded up $0.22 during midday trading on Friday, hitting $10.11. The stock had a trading volume of 31,277 shares, compared to its average volume of 264,061. The firm's fifty day moving average is $9.17 and its two-hundred day moving average is $11.10. The company has a current ratio of 5.47, a quick ratio of 4.51 and a debt-to-equity ratio of 3.02. The company has a market capitalization of $334.44 million, a PE ratio of -12.06 and a beta of 1.90. NeuroPace has a 52-week low of $5.45 and a 52-week high of $18.98.

NeuroPace (NASDAQ:NPCE - Get Free Report) last announced its quarterly earnings data on Tuesday, August 12th. The company reported ($0.26) EPS for the quarter, missing the consensus estimate of ($0.24) by ($0.02). NeuroPace had a negative net margin of 29.29% and a negative return on equity of 168.61%. The firm had revenue of $23.52 million for the quarter, compared to the consensus estimate of $23.08 million. NeuroPace has set its FY 2025 guidance at EPS. On average, research analysts forecast that NeuroPace will post -1 EPS for the current year.

NeuroPace Company Profile

NeuroPace, Inc operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely.